10-year

10-Year Anniversary Promotion (20% off)

Join GuruFocus Premium Membership Now for Only $279/Year

The largest discount in the last 10 years

Save up to $500 on Global Membership.

Don't Miss It !

Free 7-day Trial
All Articles and Columns »

Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker buys 11,800 Shares

November 20, 2012 | About:
insider

insider

57 followers
CEO of Progenics Pharmaceuticals, Inc. (PGNX) Mark Robert Baker buys 11,800 shares of PGNX on 11/19/2012 at an average price of $1.96 a share.

Progenics Pharmaceuticals, Inc. has a market cap of $63 million; its shares were traded at around $2.18 with and P/S ratio of 0.7.

This is the annual revenues and earnings per share of PGNX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of PGNX.


CEO Recent Trades:



  • CEO Mark Robert Baker bought 11,800 shares of PGNX stock on 11/19/2012 at the average price of 1.96. Mark Robert Baker owns at least 155,265 shares after this. The price of the stock has increased by 11.22% since.
  • CEO Mark Robert Baker bought 49,793 shares of PGNX stock on 11/16/2012 at the average price of 1.82. Mark Robert Baker owns at least 143,465 shares after this. The price of the stock has increased by 19.78% since.
  • CEO Mark Robert Baker bought 48,833 shares of PGNX stock on 11/15/2012 at the average price of 1.69. Mark Robert Baker owns at least 93,672 shares after this. The price of the stock has increased by 28.99% since.
  • CEO Mark Robert Baker bought 1,162 shares of PGNX stock on 10/24/2012 at the average price of 2.96. Mark Robert Baker owns at least 44,839 shares after this. The price of the stock has decreased by 26.35% since.
  • CEO Mark Robert Baker bought 1,036 shares of PGNX stock on 09/26/2012 at the average price of 3.32. Mark Robert Baker owns at least 43,677 shares after this. The price of the stock has decreased by 34.34% since.

This is the insider trade history vs. stock price of PGNX. For the complete insider trading history of PGNX, click here.




Directors and Officers Recent Trades:



  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 07/02/2012 at the average price of 9.79. Robert J Israel owns at least 35,050 shares after this. The price of the stock has decreased by 77.73% since.
  • Senior VP Medical Affairs Robert J Israel sold 1,000 shares of PGNX stock on 06/01/2012 at the average price of 8.51. Robert J Israel owns at least 38,383 shares after this. The price of the stock has decreased by 74.38% since.


For the complete insider trading history of PGNX, click here.
  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

insider
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK